Product Description
Human Breast Cancer (EPHB4/EPHB2 Receptor/Ligand) Cell Culture - Frozen Vial
Also Avaliable as:
T25 plated cells shipped at room temperature. Cat# 77013-07-T25
T75 plated cells shipped at room temperature. Cat# 77013-07-T75
120 Population doublings or up to 12 passages.
One million viable cells upon thawing of frozen cells, frozen vial of cells shipped in dry-ice.
This product would require pre-coated flasks with Human Breast Cancer (EPHB4/EPHB2 Receptor/Ligand) Cell Culture Extra-cellular Matrix Cat# E77013-07 and Human Breast Cancer (EPHB4/EPHB2 Receptor/Ligand) Cell Culture Media Cat# M77013-07
Source: Human Breast Cancer tissue.
Positive Markers: Telomerase, Her 2+, CD44, CD31, EPHB4 (Ephrin 4) Receptor & EPHB2 Ligand
For non-academic use please inquire for pricing.
1000 individual donors are fully characterized proprietary patient-derived xenografts (PDX) representing all major histotypes and capturing tumor diversity.
Subcutaneous, orthotopic and disseminated models. Extensive molecular and pharmacological characterization as well as information on patients' pretreatment to help you select the most appropriate model.
Integrated approach: use the same PDX models and/or the corresponding cell line in 2D/3D screening assays and follow-up in vivo studies, identify biomarkers predicting tumor sensitivity for your compound.
Individually tailored study designs: proof of concept, dose level and schedule optimization, combinations, biomarker identification, etc.
Publication
